Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
06/27/2011
Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
05/31/2011
Lexicon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
05/09/2011
Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
05/03/2011
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results
04/26/2011
Lexicon to Provide First Quarter 2011 Financial Results
03/29/2011
Lexicon Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference
03/24/2011
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
03/01/2011
Lexicon Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
02/24/2011
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
02/15/2011
Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 3 of 41
